ストックスクリーナーアプリを入手
53.31
1.88%
-0.8251
前日終値:
$54.14
開ける：
$53.37
24時間の取引高:
353.45K
Relative Volume:
0.15
時価総額：
$8.36B
収益：
$1.17B
当期純損益:
$150.71M
株価収益率:
56.72
EPS:
0.94
ネットキャッシュフロー:
$245.03M
1週間 パフォーマンス:
+3.08%
1か月 パフォーマンス:
+5.15%
6か月 パフォーマンス:
-28.92%
1年 パフォーマンス:
-31.29%
1日の値動き範囲:
$52.29
$53.67
1週間の範囲:
$51.26
$55.52
52週間の値動き範囲:
$46.01
$83.62
Bio Techne Corp Stock (TECH) Company Profile
TECH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
53.33 | 8.08B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.58 | 117.98B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.54 | 58.10B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
316.49 | 42.26B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
569.28 | 33.42B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
251.05 | 26.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-30 | 開始されました | Wells Fargo | Overweight |
| 2025-04-09 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | 開始されました | Evercore ISI | Outperform |
| 2025-02-19 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-02-08 | 開始されました | Scotiabank | Sector Outperform |
| 2024-02-02 | ダウングレード | Stifel | Buy → Hold |
| 2023-12-07 | 開始されました | UBS | Buy |
| 2023-08-28 | 開始されました | William Blair | Outperform |
| 2023-01-10 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-12-12 | アップグレード | Citigroup | Neutral → Buy |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-04-25 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | アップグレード | Stifel | Hold → Buy |
| 2021-01-25 | 繰り返されました | The Benchmark Company | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 開始されました | Atlantic Equities | Overweight |
| 2020-07-15 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | ダウングレード | Stifel | Buy → Hold |
| 2020-05-14 | 開始されました | The Benchmark Company | Buy |
| 2020-01-08 | 再開されました | Stephens | Overweight |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Neutral |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-07-02 | アップグレード | Janney | Neutral → Buy |
| 2019-01-14 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | ダウングレード | Craig Hallum | Buy → Hold |
| 2018-10-17 | 開始されました | Goldman | Neutral |
| 2018-06-15 | 開始されました | Argus | Buy |
| 2017-07-13 | 開始されました | Wells Fargo | Market Perform |
| 2017-02-09 | 開始されました | Citigroup | Buy |
| 2017-01-18 | 開始されました | Deutsche Bank | Buy |
| 2016-11-10 | 再開されました | Leerink Partners | Outperform |
| 2015-01-21 | 繰り返されました | Robert W. Baird | Outperform |
| 2013-09-20 | アップグレード | Robert W. Baird | Neutral → Outperform |
すべてを表示
Bio Techne Corp (TECH) 最新ニュース
Bio-techne’s technology supports FDA approval of rare skin disorder therapy - Investing.com
Bio-Techne's Simple Western Enables Breakthrough FDA Approval for Rare Skin Disease Gene Therapy - Stock Titan
Bio-Techne stock price target lowered to $75 by Scotiabank - Investing.com South Africa
Minnesota's highest-paid CEOs made 7% more, with highest paid making $59.4M - Star Tribune
Assessing Bio-Techne: Insights From 7 Financial Analysts - Benzinga
Bio-Techne (TECH) Receives Buy Rating with $65 Price Target from TD Cowen | TECH Stock News - GuruFocus
Bio-Techne (TECH): TD Cowen Initiates Coverage with Buy Rating | - GuruFocus
5 Revealing Analyst Questions From Bio-Techne’s Q1 Earnings Call - Yahoo Finance
Is There Now An Opportunity In Bio-Techne Corporation (NASDAQ:TECH)? - Yahoo Finance
How To Trade (TECH) - news.stocktradersdaily.com
Bio-Techne's New USP Deal on mAb and Gene Therapy May Boost Its Stock - Yahoo Finance
Bio-Techne stock holds steady as Stifel maintains $60 price target - Investing.com
Is Bio-Techne Stock Underperforming The Nasdaq? - Barchart.com
Major Breakthrough: Bio-Techne and USP Join Forces to Transform Gene Therapy Development Process - Stock Titan
First Week of August 15th Options Trading For Bio-Techne (TECH) - Nasdaq
Bio-Techne (NASDAQ:TECH) stock performance lags Nasdaq Composite in recent years - Kalkine Media
Bio-Techne Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
How the (TECH) price action is used to our Advantage - news.stocktradersdaily.com
Bio-Techne Director Cashes Out in Significant Stock Sale - TipRanks
Bio-Techne at Goldman Sachs Conference: Strategic Growth Amid Challenges - Investing.com
TECH Q1 Earnings Call: Management Highlights Market Uncertainties and Strategic Mitigation Efforts - Yahoo Finance
Transcript : Bio-Techne Corporation Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 10 - MarketScreener
Bio-Techne To Present At Goldman Sachs Global Healthcare Conference; Webcast At 10:40 AM ET - Nasdaq
ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics - Yahoo Finance
Bio-Techne (TECH) Maintains 'Buy' Rating with $75 Price Target | TECH Stock News - GuruFocus
Benchmark maintains Buy rating on Bio-Techne stock amid tariff impact By Investing.com - Investing.com South Africa
Benchmark maintains Buy rating on Bio-Techne stock amid tariff impact - Investing.com India
Stochastic Optical Reconstruction Miicroscope Market Size, - openPR.com
Deutsche Bank Adjusts Bio-Techne Price Target to $66 From $70 - marketscreener.com
Bio-Techne at Jefferies Conference: Strategic Growth Amid Challenges - Investing.com
Transcript : Bio-Techne Corporation Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 03 - marketscreener.com
Bio-Techne at William Blair Growth Stock: Strategic Insights and Challenges - Investing.com
Transcript : Bio-Techne Corporation Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 02 - marketscreener.com
Spotting Winners: Bio-Techne (NASDAQ:TECH) And Research Tools & Consumables Stocks In Q1 - Yahoo Finance
Bio-Techne Corp (TECH) Stock Analysis: Unveiling a 43% Potential Upside Amid Challenging Valuations - DirectorsTalk Interviews
Wells Fargo Begins Coverage of Bio-Techne (TECH) Stock, Gives PT of $59 - Insider Monkey
Wells Fargo starts Bio-Techne with Overweight, $59 target - Investing.com Australia
Bio-Techne stock price target cut to $65 by Argus - Investing.com South Africa
Wells Fargo Initiates Coverage on Bio-Techne (TECH) with Overwei - GuruFocus
Wells Fargo starts Bio-Techne with Overweight, $59 target By Investing.com - Investing.com Canada
Demystifying Bio-Techne: Insights From 7 Analyst Reviews - Benzinga
Argus Adjusts Price Target on Bio-Techne to $65 From $90 - marketscreener.com
Wells Fargo Initiates Bio-Techne at Overweight With $59 Price Target - marketscreener.com
Bio-Techne Corporation (TECH): A Bull Case Theory - Insider Monkey
Bio-Techne Corporation: An Insight Into The Pharmaceutical Market Dynamics & China's Economic & Regulatory Environment! - Smartkarma
Is Bio-Techne Stock The Right Pick For Your Portfolio Now? - Barchart.com
Is Bio-Techne Stock the Right Pick for Your Portfolio Now? - Yahoo Finance
Bio-Techne Sets Triple Conference Appearance: William Blair, Jefferies, and Goldman Sachs in June - Stock Titan
Bio-Techne to Present at Investor Conferences - Yahoo Finance
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MSN
Cetera Investment Advisers Sells 887 Shares of Bio-Techne Co. (NASDAQ:TECH) - Defense World
Bio Techne Corp (TECH) 財務データ
収益
当期純利益
現金流量
EPS
Bio Techne Corp (TECH) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Herr Amy E. | Director |
Jun 09 '25 |
Sale |
49.77 |
1,280 |
63,705 |
1,976 |
0.26%
0.84%
大文字化:
|
ボリューム (24 時間):